首页> 外文期刊>Nephron >Comparable Outcomes in Type 2 Diabetic Patients with Diabetic or Vascular Nephropathy Treated by Hemodialysis
【24h】

Comparable Outcomes in Type 2 Diabetic Patients with Diabetic or Vascular Nephropathy Treated by Hemodialysis

机译:血液透析治疗2型糖尿病合并糖尿病或血管性肾病的患者的可比结果

获取原文
获取原文并翻译 | 示例
           

摘要

Aim.The aim of the present study was to find out any differences In the progression of macroangiopathic diseases and patient survival in diabetic patients with diabetic nephropathy (DN) or diabetic renal vasculopathy (DV) under hemodi-alysis therapy. Methods: We compared 24 type 2 diabetic patients under hemodialysis with DV and 102 type 2 diabetic patients under hemodialysis with DN. Observation period was the first 3 years after initiating dialysis therapy. Results: Patients with DN were younger and their diabetes duration was longer (p < 0.05) than in the DV patients. The prevalence of vascular diseases at the start of dialysis treatment as well as after 3 years was not significantly different between both groups. The 3-year mortality was 50% in the DN group and 46% in the DV patients Conclusion: Patients with DN and DV show a similar poor outcome during the first 3 years of hemodialysis therapy.
机译:目的:本研究的目的是发现接受血液透析分析的糖尿病肾病(DN)或糖尿病肾血管病(DV)的糖尿病患者大血管病的进展和患者生存率的差异。方法:我们比较了24例接受DV血液透析的2型糖尿病患者和102例接受DN血液透析的2型糖尿病患者。观察期为开始透析治疗后的前三年。结果:DN患者比DV患者年轻,糖尿病持续时间更长(p <0.05)。两组在透析治疗开始以及3年后的血管疾病患病率无显着差异。 DN组的3年死亡率为50%,DV组的3年死亡率为46%。结论:在血液透析治疗的前3年中,DN和DV患者的预后相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号